Hemostasis analyzer Hemochron Signature Elite, manufacturer: Werfen, USA

The Hemochron Signature Elite system offers the broadest menu of rapid coagulation measurement and monitoring, covering both high and low heparin levels (ACT+, ACT-LR), as well as PT and APTT, in both coagulation pathways. It is ideal for a wide range of field situations: cardiovascular operating room, cardiac catheterization laboratory, emergency department, intensive care unit, trauma surgery and dialysis.

Any dosage. Any patient. Any user.

ACT+ accurately measures heparin activity (1.0–6.0 U/mL blood). ACT-LR, which is sensitive to low doses of heparin (0.0–2.5 U/mL blood), is the only low-range POC test designed for use in ECLS, hemodialysis, and PTCA. PT/Citrate PT indicates INR with an effective range of 0.8–10.0, plasma equivalent seconds, and whole blood seconds. APTT/Citrate APTT indicates plasma equivalent seconds and whole blood seconds.

Full menu of tests: ACT+, ACT-LR, PT, Citrate PT, APTT, Citrate APTT

Fast, accurate and reproducible results for dose adjustment and clinical decision making. True fibrin clot formation faster than any other system. Simple cassette-based technology measures fibrin formation.

To optimize efficiency and ensure regulatory compliance: Automated internal electronic quality control (QC) with cartridge lockout and expiration, as well as user tracking and lockout. Direct connection via Ethernet to leading data management systems. Compatible with POCT-1A.